Disclosure under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended.
Board Meeting Outcome for Disclosure Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015, As Amended.
Filed with BSE ·
6ix hasn’t read this filing yet.
View original source (BSE India)Supha Pharmachem Ltd on 6ix
Earlier from Supha Pharmachem
- Supha Pharmachem Ltd Press Release May 13 2025
- Announcement under Regulation 30 (LODR)-Press Release / Media Release
- Supha Pharmachem Ltd Press Release May 08 2025
- Supha Pharmachem Ltd Press Release May 05 2025
- Supha Pharmachem Ltd Press Release Apr 28 2025
Later from Supha Pharmachem
- Board Meeting Intimation for Meeting Scheduled To Be Held On 30.05.2025.
- Supha Pharmachem Ltd Press Release May 27 2025
- Compliances-Reg.24(A)-Annual Secretarial Compliance
- The Audited Financial Results (Standalone And Consolidated) Of The Company For The Last Quarter And Year Ended March 31, 2025 And Audited Annual Accounts Of The Company For The Quarter And Year Ended 31St March, 2025
- Board Meeting Outcome for The Audited Financial Results (Standalone And Consolidated) Of The Company For The Last Quarter And Year Ended March 31, 2025 And Audited Annual Accounts Of The Company The Quarter And Year Ended 31St March, 2025
Follow Supha Pharmachem into a list and get an email when it puts out news.
Follow Supha Pharmachem